Anavex Life Sciences Corp (AVXL)

[skitahoe]

The justification of the high cost of drugs isn't the cost of making them, it's the cost of developing them, and others that failed. It's the cost of all the clinical trials, and equally important the cost of developing new drugs for the future. BP's have Congress convinced that it costs billions to bring a new drug to market, yet most of the new drugs aren't developed by them, they acquire them by either purchasing companies, or rights to promising products. Most of the really innovative work is really being done in tiny biotech's and other research institutions like UCLA, and City of Hope from personal experience.

Personally I'd like an overhaul of the entire industry, starting with lower costs for product development because the FDA streamlined the process. It shouldn't take million page applications, the FDA ought to be in the field checking on promising products, with enough evidence, they should either approve right then and there, or issue an EUA permitting the sale while further support is developed for full approval. I really believe if FDA experts spoke with patients and Drs. working with the people in the companies various trials, they could find sufficient evidence to at least provide an EUA authorizing sales. If you dramatically reduce the cost of getting products to at least the EUA stage, where money is coming in, the overall price of products could come down dramatically and BP's and others would still be very profitable.

Gary